Healthcare -
Biotechnology - NASDAQ - GB
$ 0.5799
-1.71 %
$ 148 M
Market Cap
-3.41
P/E
ADAP - INTEREST INCOME & EXPENSE
Interest Income & Expense ADAP - Adaptimmune Therapeutics plc
0
LAST VALUE
0.00%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR